Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium
· Delayed Price · Currency is EUR 5.30
-0.24 (-4.33%)
Dec 20, 2024, 5:35 PM CET
Hyloris Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -13.24 | -15.38 | -11.91 | -11.58 | -7.15 | -5.37 | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.3 | 0.15 | 0.11 | 0.1 | 0.1 | Upgrade
|
| Other Amortization | 0.05 | 0.05 | 0.08 | - | 1.47 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.02 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.01 | - | - | 0.02 | 0.48 | 3.2 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.11 | 0.15 | 0.13 | 0.19 | - | - | Upgrade
|
| Stock-Based Compensation | -0.7 | 0.54 | 0.56 | 0.58 | 0.49 | - | Upgrade
|
| Other Operating Activities | -0.76 | -0.7 | -0.06 | 0.2 | 0.01 | -0.41 | Upgrade
|
| Change in Accounts Receivable | -0.53 | 0.03 | -0.92 | -2.07 | 0.08 | 0.81 | Upgrade
|
| Change in Accounts Payable | 2.13 | 1.05 | -0.47 | - | -1.4 | -0.11 | Upgrade
|
| Change in Other Net Operating Assets | 0.48 | 1.16 | -0.59 | 1.29 | 1.35 | -2.79 | Upgrade
|
| Operating Cash Flow | -12.02 | -12.81 | -13.02 | -11.25 | -4.57 | -4.56 | Upgrade
|
| Capital Expenditures | -0.32 | -0.3 | -0.1 | -0.11 | - | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.26 | -0.45 | -0.64 | -0.74 | -0.62 | -1.22 | Upgrade
|
| Investment in Securities | 5 | 10 | -10.5 | -2.23 | -0.01 | 0 | Upgrade
|
| Other Investing Activities | 0.94 | 0.64 | 0.52 | -0 | - | -0 | Upgrade
|
| Investing Cash Flow | 5.36 | 9.89 | -11.37 | -3.08 | -0.63 | -1.23 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 15.15 | - | Upgrade
|
| Long-Term Debt Issued | - | 0.05 | - | - | 3.25 | 3.36 | Upgrade
|
| Total Debt Issued | 0.15 | 0.05 | - | - | 18.4 | 3.36 | Upgrade
|
| Long-Term Debt Repaid | - | -0.17 | -7.46 | -0.06 | -8.1 | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | -0.07 | -0.12 | -7.46 | -0.06 | 10.3 | 3.31 | Upgrade
|
| Issuance of Common Stock | - | - | 17.17 | - | 64.39 | - | Upgrade
|
| Other Financing Activities | -0 | -0.01 | -1.88 | - | -5.3 | -0 | Upgrade
|
| Financing Cash Flow | -0.08 | -0.13 | 7.84 | -0.06 | 69.4 | 3.31 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -6.73 | -3.05 | -16.56 | -14.39 | 64.19 | -2.48 | Upgrade
|
| Free Cash Flow | -12.34 | -13.11 | -13.12 | -11.36 | -4.57 | -4.57 | Upgrade
|
| Free Cash Flow Margin | -177.71% | -311.01% | -549.69% | -366.83% | -2611.43% | -5021.98% | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.47 | -0.48 | -0.44 | -0.21 | -0.32 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.01 | 1.88 | - | - | 0 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.35 | - | -0 | -0 | Upgrade
|
| Levered Free Cash Flow | -6.92 | -7.44 | -10.4 | -3.54 | -2.24 | -5.13 | Upgrade
|
| Unlevered Free Cash Flow | -6.86 | -7.41 | -10.27 | -3.2 | -1.71 | -4.88 | Upgrade
|
| Change in Net Working Capital | -2.54 | -2.36 | 3.12 | -3.41 | -0.03 | 2.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.